MENLO PARK, Calif., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the BIO Investor Forum in San Francisco at 8:30 a.m. Pacific Time on Wednesday, October 21.
A live webcast of the presentation will be available through the Investor Relations pages of Geron’s website and at http://www.veracast.com/webcasts/bio/investorforum2015/39202230749.cfm. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.